Corporate Announcements
- BUDESONIDE INHALATION APPROVAL
- DARUNAVIR TAB APPROVAL
- RYZENEUTA USFDA APPROVAL
- TESTOSTERONE CYPRIONATE INJ APPROVAL
- ANTI HIV TRIPLE COMBINATION LAUNCH
- VANCOMYCIN INJ APPROVAL
- SAXAGLIPTIN TAB APPROVAL
- PLERIXAFOR INJ USFDA APPROVAL
- SEVELAMER HCL TAB APPROVAL
- TRASTUZUMAB BIOSIMILAR POSITIVE P3 RESULT
- MPP GX NILOTINIB LICENSING
- CARBOPROST TROMETHAMINE APPROVAL